文献速递细胞病理与分子病理

质子核磁共振代谢组学鉴别良恶性胸腔积液并靶向小分子生物标志物

Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
PubMed 文献 · Cancer Cytopathol · 2017-01-31

本研究对92例胸腔积液(44例恶性,来自8种不同癌症;48例良性,来自7种非肿瘤性疾病)进行1H-NMR代谢谱分析,并采用Light标准将积液分为漏出液与渗出液。结果显示,恶性与良性积液在脂质、支链氨基酸和乳酸信号区域存在明显差异,且这些代谢物在恶性积液中升高;良性积液中的漏出液与渗出液也可基于脂质和脂蛋白信号区分,渗出液中这些信号升高。作者认为1H-NMR代谢组学可能成为胸腔积液诊断的有效辅助工具,但需进一步大样本验证。

要点

  • 1H-NMR代谢谱在脂质、支链氨基酸和乳酸区域可区分良恶性胸腔积液。
  • 恶性积液中脂质、支链氨基酸和乳酸相关信号升高。
  • 良性积液中漏出液与渗出液可依据脂质和脂蛋白信号区分,渗出液中升高。

核心结论

  • 1H-NMR代谢组学可能成为胸腔积液检查与诊断的有效且可靠的辅助工具,但需进一步更大规模研究验证。

研究设计与样本

  • 对92例胸腔积液进行1H-NMR代谢谱分析,其中恶性44例(来自8种不同癌症),良性48例(来自7种非肿瘤性疾病)。
  • 采用Light标准将胸腔积液进一步分类为漏出液或渗出液。
  • 使用1H-NMR波谱区分恶性胸腔积液与良性胸腔积液。

主要发现

  • 1H-NMR代谢分析显示,恶性与良性胸腔积液在脂质、支链氨基酸和乳酸信号区域的光谱明显不同,这些信号在恶性积液中升高。
  • 良性胸腔积液中的漏出液与渗出液也可基于脂质和脂蛋白的1H-NMR信号区分,这些信号在渗出液中升高。

临床怎么用

  • 在胸腔积液细胞学诊断受限时,可考虑1H-NMR代谢组学作为辅助手段区分良恶性积液。
  • 该技术尚处于研究阶段,需进一步大样本验证后方可用于临床决策。

局限性

  • 研究结论需在进一步更大规模研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cytopathology is a noninvasive and cost-effective method for detecting cancer cells in pleural effusions (PEs), although in many cases, the diagnostic performance is hindered by the paucity of significant cells or the lack of clear morphological criteria. This study presents the results of an omics approach to improving the diagnostic performance of PE cytology. METHODS: Metabolic profiling with proton nuclear magnetic resonance (1 H-NMR) was performed for 92 PEs (44 malignant cases of 8 different cancers and 48 benign cases of 7 nonneoplastic conditions). Light's criteria were used to further classify PEs as transudates or exudates, and 1 H-NMR spectroscopy was used to differentiate malignant pleural effusions (mPEs) from benign pleural effusions (bPEs). RESULTS: 1 H-NMR metabolic analysis showed clearly different spectra for mPEs and bPEs in the regions of the signals due to lipids, branched amino acids, and lactate, which were increased in mPEs. Transudates and exudates in bPEs were differentiated as well on the basis of the 1 H-NMR signals from lipids and lipoproteins, which were increased in exudates. CONCLUSIONS: Subject to validation in further larger studies, 1 H-NMR metabonomics could be an effective and reliable ancillary tool for PE investigations and diagnoses. Cancer Cytopathol 2017;125:341-348. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Zennaro L, Vanzani P, Nicolè L, et al. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers. Cancer Cytopathol. 2017. PMID: 28140518. doi:10.1002/cncy.21832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。